# Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana

> **NCT00164281** · PHASE4 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 2000 (actual)

## Conditions studied

- Tuberculosis
- HIV Infections

## Interventions

- **DRUG:** Isoniazid

## Key facts

- **NCT ID:** NCT00164281
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2009-07
- **Final completion:** 2011-05
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2014-02-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00164281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00164281, "Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00164281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*